Vanguard Group Inc Anavex Life Sciences Corp. Put Options Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AVXL
# of Institutions
196Shares Held
31.9MCall Options Held
1.16MPut Options Held
804K-
Black Rock Inc. New York, NY6.39MShares$58.1 Million0.0% of portfolio
-
State Street Corp Boston, MA2.95MShares$26.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.02MShares$18.4 Million0.0% of portfolio
-
Nwam LLC Mercer Island, WA1.02MShares$9.31 Million0.83% of portfolio
-
Two Sigma Investments, LP New York, NY973KShares$8.85 Million0.02% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $709M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...